Today’s AI Top Pick: GPI
8/6/2026 · Low Float Bullish Consensus Deep Rotation screen · a free sample of K3vl4r’s AI-curated picks.
AI-ranked from a screened shortlist, with entry strategy, targets, and risks.
View the live GPI price forecast →
Group 1 Automotive (GPI) is the cleanest confluence of strong fundamentals, constructive multi-timeframe forecasts, and a non-extended entry. Fundamentally it is the strongest 'real business' in the pool after MORN: PE 11.57, PEG 0.75, fwdPe just 6.17, ROE 9.4, profit margin 1.29 with $3.31B cap and 99.09% institutional ownership. Analyst recom is 1.87 with a 39.7% target upside, and the fundamental_score of 6.25 is second only to MORN — but unlike MORN, GPI is not extended. The tape is what tips it. 4h forecast is +20.95/+26.45/+30.42, 1d is +12.85/+35.15/+37.95, and even the weaker 1wk is +4.14/+7.85 mid/long. Bullish_prob = 1 and near_term_bullish = 1. Critically, pos_in_21bar_range is 16.89 / 4.23 / 0.00 — this is at the BOTTOM of the range with drawdowns of -6.04% / -21.5% / -21.33%. That is exactly the 'not chasing' setup the mandate rewards: forecasts skew up while price sits near range lows on all three timeframes. RSI 37.85 is oversold on the daily. Why today, not later: MORN (7.25 fund score) is pinned at 100% of range across all TFs with 4h/1d forecasts NEGATIVE — a classic chase. TASK (fund score 4.25) is similarly at 100/100/84 with a negative 4h short forecast. IDN has bigger forecast magnitude but PE 35, fwdPe 22, and a NEGATIVE 1wk long forecast (-12.42%). GPI is the only name combining top-quartile fundamentals, sub-25% range position on every TF, and unanimously positive short/mid-horizon forecasts. On news, JPM lowered PT to $275 and Evercore to $360 on Aug 4 — but both MAINTAINED their ratings (Neutral/Outperform), meaning the recent cut is already in the tape (hence the -29.42% YTD and price near range lows). No dilution, no legal overhang, no short-seller report. This is a fundamentally sound cyclical bought at the low end of its recent range with forecast confirmation across timeframes.
- Auto retail cyclicality — perfYear -33.91% and salesYoY only +0.81% show demand softness; a weak macro print could extend the downtrend
- Two brokerage PT cuts on Aug 4 (JPM $275, Evercore $360) signal analyst caution even if ratings maintained
- DebtEq 1.86 is elevated for a low-margin retailer (profit margin just 1.29%) — rate-sensitive
- 1wk fc_short is -0.78% — the weekly timeframe is not yet confirming, so a fresh leg down is possible before the reversal
- Position at 0% of weekly range with -21.33% DD means the downtrend is real; false-bottom risk exists
| # | Symbol | Verdict | Score | Read |
|---|---|---|---|---|
| 1 | GPI | BUY NOW | 7.8 | Profitable large-cap at 0–17% of range on all TFs with unanimously positive short/mid forecasts and PE 11.6/PEG 0.75. |
| 2 | IDN | BUY NOW | 7.1 | Strong 4h/1d forecasts and low range position, but rich valuation and negative 1wk long forecast cap conviction. |
| 3 | EVGN | BUY PULLBACK | 6.2 | Positive pipeline catalysts + huge 1wk forecasts, but extended near-term with 1d at 100% of range. |
| 4 | TNXP | BUY PULLBACK | 5.8 | FDA Type C minutes for TNX-4800 + Medicare coverage expansion; near_term_bullish only 0.2 argues for patience. |
| 5 | MORN | WAIT | 5.7 | Best fundamentals (score 7.25) but pinned at 100% of range on every TF with negative 4h/1d forecasts — chase risk. |
| 6 | GRCE | WAIT | 5.5 | Positive FDA Type A minutes but a fresh $10M PP announced Aug 5 = imminent dilution overhang. |
| 7 | LTRN | BUY PULLBACK | 5.4 | Open-Medicine AI spinoff + EMA clearance are real catalysts, but 4h fc_mid/long turned negative. |
| 8 | TASK | BUY PULLBACK | 5.3 | Cheap (PE 5.57/fwdPe 4.16) but 4h/1d at 100% of range post-earnings; wait for a dip. |
| 9 | LBRDA | WAIT | 5.0 | Bullish setup but at 99% of 4h/1d range — no margin of safety at $36. |
| 10 | BCDA | BUY PULLBACK | 4.9 | Micro-cap with 1wk fc +158/+137/+198, but salesYoY -100% and no revenue is a structural red flag. |
| 11 | QNTM | BUY PULLBACK | 4.8 | Positive Lucid-MS narrative and debt settlement close; sits at 9–10% of range with strong forecasts. |
| 12 | INDP | BUY PULLBACK | 4.7 | RSI 31, 1wk fc +473/+577/+810 but 4h -51% DD — knife-catch until short-term stabilizes. |
| 13 | GLMD | BUY PULLBACK | 4.6 | Aramchol pipeline progress in Parkinson's/cardio, decent forecasts, but no 1wk data and micro cap $4.8M. |
| 14 | XTLB | WAIT | 4.5 | 1wk forecasts strong (+25/+76/+119) but 4h forecasts modest and thin liquidity. |
| 15 | DRMA | WAIT | 4.3 | 1wk fc +5486%/+12454%/+10539% is a nonsensical outlier — model artifact, do not trust. |
| 16 | NXTC | WAIT | 4.2 | Avere reverse-merger + $320M PP fundamentally changes the ticker — wait for the dust to settle. |
| 17 | PRSO | BUY PULLBACK | 4.1 | 1wk fc +476/+431/+160 but salesYoY -40.57% and no fresh catalyst. |
| 18 | NXL | AVOID | 3.9 | PS 26.76 and profitMargin -3022% with no news — junk paper. |
| 19 | DARE | BUY PULLBACK | 3.9 | Commercial launch updates and 1d/1wk forecasts strong, but debtEq 9.84 and -35% DD show structural weakness. |
| 20 | RGNT | WAIT | 3.8 | Two positive patent/regulatory items in July, but only 1d TF available and -44.51% recent. |
| 21 | ANNA | BUY PULLBACK | 3.7 | Profitable ($17.43% margin) with SeekingAlpha bull thesis, but 1wk -64.92% and RSI 31.43. |
| 22 | WW | WAIT | 3.6 | PE 0.14 is a distressed signal, not value; earnings-day only 1d TF available. |
| 23 | HCWB | AVOID | 3.3 | $1.6M PP priced Jul 29 at $2.5849 — active dilution undercuts the +505% 1wk fc_mid. |
| 24 | LUCY | AVOID | 3.2 | Warrant exercise $3M Jul 8 = dilution; recom 3 (hold) is the weakest in the pool. |
| 25 | CNCK | AVOID | 3.1 | 56.4M share resale prospectus filed Jul 31 — massive overhang despite crypto tailwind. |
| 26 | INTZ | AVOID | 3.0 | Two Zacks 'sinks' articles in late July; profitMargin -169%, no positive catalyst. |
| 27 | IPWR | AVOID | 2.9 | $75M shelf filed Jul 10 with $68.8M market cap = >100% potential dilution overhang. |
| 28 | YCBD | AVOID | 2.8 | cbdMD micro-cap; 4h/1d fc mostly negative, only tangential distribution PR. |
| 29 | USBC | AVOID | 2.5 | Target upside 11,011% and 1wk fc +1016/+1238/+1409 are model artifacts, not opportunity. |
| 30 | COSM | AVOID | 2.2 | 1wk forecasts -100/-100/-100 signal terminal risk; $13M cap penny stock. |
Get AI top picks & forecasts on any stock
K3vl4r screens the market daily and ranks the best setups with AI — forecasts, scored fundamentals & technicals, and multi-horizon price targets. Create a free account to explore them all.
Create your free account →Already a member? Sign in · Join our Discord